Reprogramming the tumor microenvironment with biotechnology

Bibliographic Details
Title: Reprogramming the tumor microenvironment with biotechnology
Authors: Minjeong Kim, Na Kyeong Lee, Chi-Pin James Wang, Jaesung Lim, Min Ji Byun, Tae-Hyung Kim, Wooram Park, Dae-Hwan Park, Se-Na Kim, Chun Gwon Park
Source: Biomaterials Research, Vol 27, Iss 1, Pp 1-23 (2023)
Publisher Information: American Association for the Advancement of Science (AAAS), 2023.
Publication Year: 2023
Collection: LCC:Medical technology
Subject Terms: Tumor microenvironment, Reprogramming, Combination treatment, Nanoparticle, Biomaterials, Medical technology, R855-855.5
More Details: Abstract The tumor microenvironment (TME) is a unique environment that is developed by the tumor and controlled by tumor-induced interactions with host cells during tumor progression. The TME includes immune cells, which can be classified into two types: tumor- antagonizing and tumor-promoting immune cells. Increasing the tumor treatment responses is associated with the tumor immune microenvironment. Targeting the TME has become a popular topic in research, which includes polarizing macrophage phenotype 2 into macrophage phenotype 1 using Toll-like receptor agonists with cytokines, anti-CD47, and anti-SIPRĪ±. Moreover, inhibiting regulatory T cells through blockades and depletion restricts immunosuppressive cells in the TME. Reprogramming T cell infiltration and T cell exhaustion improves tumor infiltrating lymphocytes, such as CD8+ or CD4+ T cells. Targeting metabolic pathways, including glucose, lipid, and amino acid metabolisms, can suppress tumor growth by restricting the absorption of nutrients and adenosine triphosphate energy into tumor cells. In conclusion, these TME reprogramming strategies exhibit more effective responses using combination treatments, biomaterials, and nanoparticles. This review highlights how biomaterials and immunotherapy can reprogram TME and improve the immune activity.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2055-7124
Relation: https://doaj.org/toc/2055-7124
DOI: 10.1186/s40824-023-00343-4
Access URL: https://doaj.org/article/f23026eb0664467bab65572cd42a1517
Accession Number: edsdoj.f23026eb0664467bab65572cd42a1517
Database: Directory of Open Access Journals
More Details
ISSN:20557124
DOI:10.1186/s40824-023-00343-4
Published in:Biomaterials Research
Language:English